同種骨髄移植後にタクロリムス(FK506)による脳症を発症した1例
晶裕 井口, 渡辺 直樹, 吉田 真 et al. · 日本小児血液学会雑誌 · 1998
Cited by 0 works. doi:10.11412/jjph1987.12.115
Authors
References
- A Reversible Posterior Leukoencephalopathy Syndrome
- Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.
- High brain densities of the immunophilin FKBP colocalized with calcineurin
- FK506‐induced neurotoxicity in liver transplantation
- Juvenile "Chronic Granulocytic" Leukemia: A Panmyelopathy With Prominent Monocytic Involvement and Circulating Monocyte Colony-forming Cells
- Immunosuppression‐induced leukoencephalopathy from tacrolimus (FK506)
- Sensorimotor neuropathy resembling CIDP in patients receiving FK506
- An inhibitor for calcineurin, FK506, blocks induction of long-term depression in rat visual cortex
- Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.
- Psychopharmacologic Issues in Organ Transplantation